Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BYScientific Reports

d-dopachrome tautomerase promotes astrocytic cholesterol 25-hydroxylase expression through the ERK/NF-κB pathway following rat spinal cord injury

  • Huiyuan Ji1
  • Hui Li2
  • Dongyan Zhu1
  • Liang Wang1
  • Yuejiao Cao1
  • Jiajia Zhai1
  • Dehui Xu1
  • Bingqiang He2
  • Weiguan Chen1
  1. 1Department of Rehabilitation Medicine, Affiliated Nantong Clinical College of Nantong University, Nantong First People’s Hospital
  2. 2Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University
Read full textDOICite

Abstract

Astrocytes act as crucial cellular centres of cholesterol synthesis and metabolism and help maintain homeostasis in the healthy CNS. Spinal cord injury (SCI) results in abnormalities in astrocytic cholesterol metabolism and excessive oxysterol accumulation, contributing to the activation of inflammation. However, the relevant regulatory mechanism involved in aberrant cholesterol metabolism by astrocytes has not been fully elucidated. In the present study, we demonstrated that SCI-induced d-DT protein levels increased synchronously with CH25H expression. Administration of the d-DT inhibitor 4-CPPC markedly decreased CH25H expression in astrocytes following SCI. d-DT facilitates CH25H production in astrocytes by activating the intracellular ERK/NF-κB pathway through binding to the CD74 receptor. Conditioned culture medium from astrocytes following the knockdown of astrocyte CH25H expression by siRNA reduced microglial migration. The inhibition of d-DT or CH25H activity reduces microglia/macrophage accumulation at the lesion site and improves motor functional recovery following SCI. Our results reveal a novel function of d-DT-mediated astrocytic CH25H activation, which modulates pathological microenvironments through the activation of inflammation. These data may provide a potential therapeutic strategy for CNS inflammation-associated diseases.

Related

  1. Differential Regulation of Cholesterol-Related Gene Expression by HDAC Inhibition in Neuron-Enriched and Glia-Enriched Rat Primary Cultures
    Alevtina A. Samorodova, Alexander P. Beletskiy, Pavel M. Balaban +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Surgery & anaesthesiaCrossref
  2. Tyrosine Hydroxylase Deficiency: From Clinical and Therapeutic Features to Pathogenetic Considerations
    YOSHIAKI FURUKAWA
    Juntendo Medical JournalPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
  3. Psychotic symptoms in tyrosine hydroxylase deficiency-associated dopa-responsive dystonia treated with antipsychotics and rTMS: a case report
    Yue Shen, Hai-Zhi Chen, Liang Lv +1
    Frontiers in PsychiatryPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  4. R278H Substitution Reduces Mouse Tyrosine Hydroxylase Activity and Increases Susceptibility to Catechol Inhibition
    Ismail Alsalloum, Ekatherine I. Terentieva, Vitalii S. Moskaliuk +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General medicineCrossref
  5. Dynamic association of APLNR with astrocytic remodeling in the cuprizone-treated corpus callosum
    Lyubomir Gaydarski, Kristina Petrova, Nikola Stamenov +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{ji2026ddopachrome,
  title = {{d-dopachrome tautomerase promotes astrocytic cholesterol 25-hydroxylase expression through the ERK/NF-κB pathway following rat spinal cord injury}},
  author = {Huiyuan Ji and Hui Li and Dongyan Zhu and Liang Wang and Yuejiao Cao and Jiajia Zhai and Dehui Xu and Bingqiang He and Weiguan Chen},
  journal = {Scientific Reports},
  year = {2026},
  month = jul,
  doi = {10.1038/s41598-026-63510-2},
  url = {https://doi.org/10.1038/s41598-026-63510-2},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - d-dopachrome tautomerase promotes astrocytic cholesterol 25-hydroxylase expression through the ERK/NF-κB pathway following rat spinal cord injury
AU  - Huiyuan Ji
AU  - Hui Li
AU  - Dongyan Zhu
AU  - Liang Wang
AU  - Yuejiao Cao
AU  - Jiajia Zhai
AU  - Dehui Xu
AU  - Bingqiang He
AU  - Weiguan Chen
PY  - 2026
DA  - 2026/07/01
JO  - Scientific Reports
DO  - 10.1038/s41598-026-63510-2
UR  - https://doi.org/10.1038/s41598-026-63510-2
AB  - Astrocytes act as crucial cellular centres of cholesterol synthesis and metabolism and help maintain homeostasis in the healthy CNS. Spinal cord injury (SCI) results in abnormalities in astrocytic cholesterol metabolism and excessive oxysterol accumulation, contributing to the activation of inflammation. However, the relevant regulatory mechanism involved in aberrant cholesterol metabolism by astrocytes has not been fully elucidated. In the present study, we demonstrated that SCI-induced d-DT protein levels increased synchronously with CH25H expression. Administration of the d-DT inhibitor 4-CPPC markedly decreased CH25H expression in astrocytes following SCI. d-DT facilitates CH25H production in astrocytes by activating the intracellular ERK/NF-κB pathway through binding to the CD74 receptor. Conditioned culture medium from astrocytes following the knockdown of astrocyte CH25H expression by siRNA reduced microglial migration. The inhibition of d-DT or CH25H activity reduces microglia/macrophage accumulation at the lesion site and improves motor functional recovery following SCI. Our results reveal a novel function of d-DT-mediated astrocytic CH25H activation, which modulates pathological microenvironments through the activation of inflammation. These data may provide a potential therapeutic strategy for CNS inflammation-associated diseases.
SN  - 2045-2322
ER  -